Research Article

Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway

Figure 5

LrB suppressed angiotensin (Ang) II-induced activation of TGF-β1/Smad signaling pathway in cardiac fibroblasts (CFs) via regulating PAI-1. (a) Representative fluorescent images of fibroblast-specific protein-1 (FSP1) and α-smooth muscle actin (α-SMA) in CFs. Scar bar = 50 μm. (b) Western blot analysis for PAI-1 in CFs transfected with empty vector or PAI-1 overexpression (OE) vector. (c, d) Relative mRNA and protein expression of PAI-1 in CFs. (e) Western blot analysis for TGF-β1R, TGF-β1, p-Smad2/3, and Smad2/3. Relative protein expression of (f) TGF-β1R, (g) TGF-β1, (h) p-Smad2/3, and (i) Smad2/3 in CFs. Values are indicated as mean ± SD (n = 3). vs. control group. vs. Ang II group. vs. Ang II + LrB + vector group.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)